acute hepatic failure
After the rats with acute hepatic failure were treated with recombinant pcDNA3-ALR plasmid, the survival rate (40%) significantly increased in treatment groups compared to control group (15%, P<0.01).
After the rats with <span class="disease" id="15968720-16-20-41">acute hepatic failure</span> were treated with recombinant pcDNA3-<span class="gene" id="15968720-16-79-82">ALR</span> plasmid, the survival rate (40%) significantly increased in treatment groups compared to control group (15%, P&lt;0.01).